Alembic Pharmaceuticals
₹984.8
0.05 (0.01%)
29 March, 2024 00:24 BSE: 533573
NSE: APLLTDISIN: INE901L01018
Start SIP in Alembic Pharmaceuticals
Start SIPAlembic Pharmaceuticals Performance
Day Range
- Low 970
- High 997
52 Week Range
- Low 462
- High 1,094
- Open Price994
- Previous Close985
- Volume141639
Alembic Pharmaceuticals Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 1,588 | 1,479 | 1,332 | 1,307 |
Operating Expenses Qtr Cr | 1,251 | 1,271 | 1,167 | 1,138 |
Operating Profit Qtr Cr | 337 | 207 | 166 | 169 |
Depreciation Qtr Cr | 69 | 67 | 66 | 74 |
Interest Qtr Cr | 15 | 15 | 14 | 14 |
Tax Qtr Cr | 23 | 0 | 0 | -47 |
Net Profit Qtr Cr | 233 | 134 | 98 | 131 |
Alembic Pharmaceuticals Technicals
EMA & SMA
Current Price
₹984.8
0.05 (0.01%)
- Bullish Moving Average
- ___
- 15
- Bearish Moving Average
- ___
- 1
- 20 Day
- ₹975.60
- 50 Day
- ₹957.39
- 100 Day
- ₹901.98
- 200 Day
- ₹823.29
- 20 Day
- ₹980.46
- 50 Day
- ₹983.04
- 100 Day
- ₹876.50
- 200 Day
- ₹803.21
Alembic Pharmaceuticals Resistance and Support
PIVOT
₹983.92
Resistance | |
---|---|
First Resistance | 998.23 |
Second Resistance | 1,011.67 |
Third Resistance | 1,025.98 |
RSI | 52.07 |
MFI | 49.19 |
MACD Single Line | -5.39 |
MACD | -5.42 |
Support | |
---|---|
First Resistance | 970.48 |
Second Resistance | 956.17 |
Third Resistance | 942.73 |
Alembic Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 146,293 | 8,113,410 | 55.46 |
Week | 100,952 | 5,752,216 | 56.98 |
1 Month | 122,759 | 6,862,241 | 55.9 |
6 Month | 307,650 | 12,247,563 | 39.81 |
Alembic Pharmaceuticals Result Highlights
Alembic Pharmaceuticals Synopsis
NSE-Medical-Generic Drugs
Alembic Pharmaceutic is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 5149.00 Cr. and Equity Capital is Rs. 39.31 Cr. for the Year ended 31/03/2023. Alembic Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 16/06/2010 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ2010PLC061123 and registration number is 061123.Market Cap | 19,398 |
Sales | 5,707 |
Shares in Float | 5.90 |
No of funds | 179 |
Yield | 0.81 |
Book Value | 4.39 |
U/D Vol ratio | 2.3 |
LTDebt / Equity | |
Alpha | 0.15 |
Beta | 1.13 |
Alembic Pharmaceuticals
Owner Name | Dec-23 | Sep-23 | Jun-23 | Mar-23 |
---|---|---|---|---|
Promoters | 69.61% | 69.61% | 69.61% | 69.61% |
Mutual Funds | 7.71% | 7.33% | 6.64% | 6.47% |
Insurance Companies | 6.52% | 6.57% | 6.74% | 6.55% |
Foreign Portfolio Investors | 4.52% | 4.51% | 4.34% | 4.55% |
Financial Institutions/ Banks | 0.03% | 0.03% | 0.03% | 0.04% |
Individual Investors | 8% | 8.24% | 8.98% | 9.08% |
Others | 3.61% | 3.71% | 3.66% | 3.7% |
Alembic Pharmaceuticals Management
Name | Designation |
---|---|
Mr. Chirayu Amin | Chairman & CEO |
Mr. Pranav Amin | Managing Director |
Mr. Shaunak Amin | Managing Director |
Mr. R K Baheti | Director - Finance & CFO |
Mr. K G Ramanathan | Independent Director |
Mr. Pranav Parikh | Independent Director |
Mr. Paresh Saraiya | Independent Director |
Dr. Archana Hingorani | Independent Director |
Mr. Ashok Barat | Independent Director |
Mr. Jai Diwanji | Independent Director |
Alembic Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Alembic Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-02-05 | Quarterly Results | |
2023-11-07 | Quarterly Results | |
2023-08-04 | Quarterly Results | |
2023-05-05 | Audited Results & Final Dividend | |
2023-02-01 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2023-07-28 | FINAL | Rs.8.00 per share(400%)Final Dividend |
2022-08-18 | INTERIM | Rs.10.00 per share(500%)Dividend (Changed Final Dividend as Interim Divided) |
Alembic Pharmaceuticals FAQs
What is Share Price of Alembic Pharmaceuticals ?
Alembic Pharmaceuticals share price is ₹984 As on 29 March, 2024 | 00:10
What is the Market Cap of Alembic Pharmaceuticals ?
The Market Cap of Alembic Pharmaceuticals is ₹19357.5 Cr As on 29 March, 2024 | 00:10
What is the P/E ratio of Alembic Pharmaceuticals ?
The P/E ratio of Alembic Pharmaceuticals is 32.8 As on 29 March, 2024 | 00:10
What is the PB ratio of Alembic Pharmaceuticals ?
The PB ratio of Alembic Pharmaceuticals is 4.4 As on 29 March, 2024 | 00:10